Sunday, October 11, 2026

Superhenge not Aligned With Winter Solstice Like Stonehenge

Mark Silva

September 7, 2015

Stonehenge is aligned with the winter solstice. Image by Simon Wakefield - License
The British Science Association announced today the discovery of about 200 standing stones (called Superhenge) just under two miles (3km) away from the Stonehenge.
"The overlying bank surrounding the Superhenge is aligned with the winter solstice, but the buried monument seems to be on a different alignment."

Professor Vince Gaffney

Recent scanning of the area with remote sensing and image technology has already unveiled 4.5 meters tall standing stones expected to be about 4500 years old. The Superhenge, called Durrington Walls, has been lost to archeology up until now and could be the largest intact prehistoric monument in Great Britain. In an interview to the BBC world news, Professor Vince Gaffney of the University of Bradford said that the overlying bank surrounding the Superhenge alignment with the winter solstice, but the buried monument seems to be on a different alignment. The original purpose of the Stonehenge is still a mystery that maybe the 15 times bigger Superhenge discovery could help to unveil.
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic AI Rewires Enterprise Software: Platform Incumbents, Governance, and a Funded Startup Wave
Enterprise software is being rebuilt around autonomous AI agents. Incumbents and large platforms (SAP with its Autonomous Suite and Joule, Zeta with AthenaOS/AIM/Athena MCP, Meta with its new Enterprise Platform) are racing to own the agent layer. Meanwhile, seed and Series A money flows to finance-office and vertical startups (Dextr, Latitude, Dentira, Light), and consolidation continues through acquisitions (Tiny–Oso Cloud, Harvey–Guardrails AI). Investor commentary stresses that AI is better at disrupting around the edges of systems of record than at replacing them, that it should not be trusted with finance calculations, and that governance must be enforced by the system rather than left to agents.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,369 source documents archived
Query this data → isubstrate.com